Page 3 - Janx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Janx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Janx Today - Breaking & Trending Today

William Blair Reiterates "Outperform" Rating for Janux Therapeutics (NASDAQ:JANX)

Janux Therapeutics (NASDAQ:JANX – Get Free Report)‘s stock had its “outperform” rating reiterated by William Blair in a research report issued on Tuesday, RTT News reports. Several other brokerages also recently commented on JANX. Wedbush upped their price objective on Janux Therapeutics from $24.00 to $53.00 and gave the company an “outperform” rating in a […] ....

Immunomodulator Tracir , William Blair , Nisa Investment Advisors , China Universal Asset Management Co , Janux Therapeutics Inc , Tower Research Capital , Barclays Plc , Citigroup Inc , Janux Therapeutics , Get Free Report , Investment Advisors , Research Capital , Universal Asset Management , Tumor Activatedt Cell Engager , Tumor Activated Immunomodulator , Janux Therapeutics Daily , Nasdaq Janx , Reiterated Rating ,

Comparing Janux Therapeutics (NASDAQ:JANX) and PaxMedica (NASDAQ:PXMD)

Janux Therapeutics (NASDAQ:JANX – Get Free Report) and PaxMedica (NASDAQ:PXMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Profitability This table compares Janux Therapeutics and PaxMedica’s […] ....

New York , United States , San Diego , Immunomodulator Tracir , Janux Therapeutics Inc , Purinix Pharmaceuticals , Paxmedica Inc , Janux Therapeutics , Get Free Report , Given Paxmedica , Tumor Activatedt Cell Engager , Tumor Activated Immunomodulator , Janux Therapeutics Daily , Nasdaq Janx , Stock Comparison , Stock Analysis ,

Janux Therapeutics (NASDAQ:JANX) & PaxMedica (NASDAQ:PXMD) Head-To-Head Review

Janux Therapeutics (NASDAQ:JANX – Get Free Report) and PaxMedica (NASDAQ:PXMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk Janux Therapeutics has a beta […] ....

New York , United States , San Diego , Immunomodulator Tracir , Paxmedica Inc , Janux Therapeutics Inc , Purinix Pharmaceuticals , Janux Therapeutics , Get Free Report , Given Paxmedica , Tumor Activatedt Cell Engager , Tumor Activated Immunomodulator , Janux Therapeutics Daily , Nasdaq Janx , Stock Comparison , Stock Analysis ,

Janux Therapeutics (NASDAQ:JANX) Stock Price Up 5.1%

Janux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) shares rose 5.1% during mid-day trading on Thursday . The stock traded as high as $9.85 and last traded at $9.50. Approximately 65,361 shares were traded during mid-day trading, a decline of 25% from the average daily volume of 86,818 shares. The stock had previously closed at […] ....

United States , Immunomodulator Tracir , Janux Therapeutics Inc , American International Group Inc , Tower Research Capital , Janux Therapeutics Company Profile , Charles Schwab Investment Management Inc , Janux Therapeutics , Get Free Report , Schwab Investment Management , Wisconsin Investment Board , International Group , Research Capital , Tumor Activatedt Cell Engager , Tumor Activated Immunomodulator , Janux Therapeutics Daily , Nasdaq Janx ,